FUSION PROTEIN OF RELAXIN OR ANALOGUE AND MEDICAL USE THEREOF

Treatment Using Heterodimeric Relaxin Fusions

INHALABLE POROUS MICROSPHERE LOADED WITH RECOMBINANT HUMAN RELAXIN-2 AND PREPARATION METHOD THEREFOR

HETERODIMERIC RELAXIN FUSIONS AND USES THEREOF

MEDICAL COMPOSITION FOR TREATING PATIENTS EXHIBITING CARDIAC DECOMPENSATION

POLYNUCLEOTIDES ENCODING RELAXIN FOR THE TREATMENT OF FIBROSIS AND/OR CARDIOVASCULAR DISEASE

Methods for Treating and Diagnosing Risk of Renal Allograft Fibrosis and Rejection

METHOD OF TREATING HEART FAILURE

HALF-LIFE EXTENDING MOIETIES AND METHODS OF USING THE SAME

LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFpEF)

Modified Relaxin Polypeptides and Their Uses

COMPOSITIONS COMPRISING RELAXIN AND METHODS OF USE THEREOF

USING MINIVECTORS TO TREAT IDIOPATHIC PULMONARY FIBROSIS

NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES

Heterodimeric Relaxin fusions and uses thereof

Synthetic cellular signaling pathways and uses thereof

TREATMENT OF LIVER CANCER OR LIVER FIBROSIS

METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASE

ENGINEERED RELAXINS AND METHODS OF USE THEREOF

Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

HUMAN ANTI-INFLAMMATORY PEPTIDES FOR THE INHALATORY TREATMENT OF INFLAMMATORY PULMONARY ISSUES

GENE DELIVERY SYSTEM CONTAINING RELAXIN GENE AND PHARMACEUTICAL COMPOSITION USING RELAXIN

Modified Relaxin Polypeptides and Their Uses

Medical composition for treating cardiac wasting and cachexia

ANTICANCER COMPOSITION COMPRISING TUMOR-SPECIFIC ONCOLYTIC ADENOVIRUS AND IMMUNE CHECKPOINT INHIBITOR

Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides

USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION

Modified relaxin polypeptides and their uses

Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides

Heterodimeric Relaxin fusions polypeptides

RELAXIN RECEPTOR 1 FOR USE IN TREATMENT AND PREVENTION OF HEART FAILURE

Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

Formulations for treating a fibrotic disease

17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure

METHOD OF TREATING HEART FAILURE

Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof

Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

Fatty acids and their use in conjugation to biomolecules

Nucleic acids encoding modified relaxin polypeptides

Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides

USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION

METHODS AND COMPOSITIONS COMPRISING VIRAL GENE THERAPY AND AN IMMUNE CHECKPOINT INHIBITOR FOR TREATMENT AND PREVENTION OF CANCER AND INFECTIOUS DISEASES

Anticancer composition comprising tumor-specific oncolytic adenovirus and immune checkpoint inhibitor

Method of treating type I diabetes using an AAV vector encoding uracortin 2

Methods for diagnosing risk of renal allograft fibrosis and rejection

Modified therapeutic agents and compositions thereof

GENE DELIVERY SYSTEM CONTAINING RELAXIN GENE AND PHARMACEUTICAL COMPOSITION USING RELAXIN

METHOD FOR TREATING AIRWAYS DISEASE

Compositions comprising relaxin and methods of use thereof

Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acid

Method for increasing cardiac inflow by administering a compound that binds RXFP1

USE OF SERELAXIN TO REDUCE GDF-15

FILTERS FOR INFUSION SETS

Treatment of disease with relaxin

Therapy for Lower Urinary Tract Dysfunctions

Fatty acids and their use in conjugation to biomolecules

Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chain

TARGETED DELIVERY OF SPRAY-DRIED FORMULATIONS TO THE LUNGS

MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF

Method of treating type I diabetes using an AAV vector encoding uracortin 2

FILTERS FOR INFUSION SETS

METHOD OF TREATING HEART FAILURE

Method for treating heart failure with preserved ejection fraction by administering human relaxin-2

Methods for diagnosing risk of renal allograft fibrosis and rejection

Method of treating dyspnea associated with acute heart failure

USE OF SERELAXIN TO REDUCE GDF-15

TREATMENT OF THE COMPLICATIONS OF CHRONIC LIVER DISEASE WITH CASPASE INHIBITORS

PPSA and Pspa polymer-virus complex and pharmaceutical compositions comprising the same

Method of treating heart failure with modified relaxin polypeptides

ANP fragment adjuvant therapy to standard of care (SOC) diuretic treatment

HUMAN RELAXIN ANALOGUE, PHARMACEUTICAL COMPOSITION OF SAME, AND PHARMACEUTICAL APPLICATION OF SAME

METHODS OF TREATING DISEASES ASSOCIATED WITH PPARy

ENGINEERED GLYCOPROTEINS AND USES THEREOF

Relaxin Prodrugs

Modified therapeutic agents and compositions thereof

METHOD OF TREATING CHRONIC HEART FAILURE BY ADMINISTERING RELAXIN

Use of relaxin to restore maternal physiology in pregnancies conceived by assisted reproductive technologies

Fatty acids and their use in conjugation to biomolecules

Method of lowering mortality

TREATING INFLAMMATION USING SERELAXIN

Relaxin for treating patients afflicted of impaired glucose tolerance

Use of relaxin to treat placental syndromes

Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

Relaxin proteins for use in the diagnosis, prevention or treatment of multiple sclerosis

Materials and methods for modulating activity of bone marrow derived cells

METHODS OF TREATING CARDIOVASCULAR INDICATIONS

Use of relaxin to restore maternal physiology in pregnancies conceived by assisted reproductive technologies

Administration of relaxin to treat nephrogenic diseases of water imbalance involving aquaporin-4

USE OF RELAXIN TO INCREASE ARTERIAL COMPLIANCE

Modified Relaxin Polypeptides

METHOD OF TREATING CHRONIC HEART FAILURE BY ADMINISTERING RELAXIN

Methods of treating diseases associated with PPARγ

PREDICTION AND PREVENTION OF PREECLAMPSIA

Method of inducing labor or treating pre-eclampsia by administering relaxin analogs

Method of lowering mortality

Method of treating neurohormonal imbalance

MODULATING AQUAPORINS WITH RELAXIN

PREDICTION AND PREVENTION OF PREECLAMPSIA

Methods of modulating apoptosis by administration of relaxin agonists or antagonists

Relaxin polypeptides comprising non-naturally encoded amino acids

Method of treating dyspnea associated with acute heart failure by administering H2 relaxin

Method of treating dyspnea associated with acute heart failure

Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle

METHODS TO IDENTIFY FACTORS ASSOCIATED WITH MUSCLE GROWTH AND USES THEREOF

METHOD OF PREVENTING PREMATURE DELIVERY

METHOD OF TREATING CHRONIC HEART FAILURE

Use of relaxin to increase arterial compliance

Relaxin analogs

METHOD OF PROMOTING WOUND HEALING

Methods of modulating apoptosis by administration of relaxin agonists or antagonists

HUMAN 3 RELAXIN

Method for treating a disease characterized by reduced appetite

METHOD OF TREATING HEART FAILURE

Treatment of Conditions Through Modulation of the Autonomic Nervous System During at Least One Predetermined Menstrual Cycle Phase

Penis Enlargement

Method of treating dyspnea associated with acute heart failure

Method of Promoting Wound Healing

Methods and compositions for control of fetal growth via modulation of relaxin

Peptide having antianxiety activity and screening method therefor

HUMAN 3 RELAXIN

METABOLIC REGULATORS AND USES THEREOF

Method and Compositions for the Treatment of Diabetes and Related Complications

THERAPEUTICS TO FACILITATE CELL TRANSPLANTATION FOR LIVER DISEASE

Method for treatment of anxiety

Methods and compositions for control of fetal growth via modulation of relaxin

Methods of modulating apoptosis by administration of relaxin agonists or antagonists

METHODS AND THERAPEUTICS TO FACILITATE LIVER REPAIR

Gene Delivery System Containing Relaxin Gene And Pharmaceutical Composition Using Relaxin

Method and compositions for the treatment of diabetes and related complications

Methods and systems for enabling and stabilizing tooth movement

Prevention of fibrosis following cardiac injury

Methods and compositions for control of fetal growth via modulation of relaxin

Methods and compositions for control of fetal growth via modulation of relaxin

Pharmaceutical formulations for sustained drug delivery

Methods of using testis-specific insulin homolog polypeptides

Method for remodeling bone and related sutures

Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase

Use of relaxin to increase arterial compliance

Methods and systems for enabling and stabilizing tooth movement

Use of relaxin for stimulating the development of activated human T cells into TH1-like effectors

Use of relaxin as adjuvant in the differentiation of stem cells for the reconstruction of tissues

Penis enlargement

Methods of modulating apoptosis by administration of relaxin agonists or antagonists

Human 3 relaxin

Materials and methods for the treatment of vascular calcification